United States Biotechnology & Medical Research

Jade Biosciences, Inc. (JBIO)

Ticker: JBIO Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Jade Biosciences, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Atlas Venture Fund XII, L.P. Shareholder
Transaction date
Proposed sale
Price
473.68
Quantity 60,746
Value US$618,361
Atlas Venture Fund XII, L.P. Shareholder
Transaction date
Proposed sale
Price
315.21
Quantity 6,869
Value US$2,805,274
0.9
Frohlich Tom Chief Executive Officer Executive Director
Transaction date
Purchase
Price
7.40
Quantity 6,000 New position
Value US$44,400
Atlas Venture Fund XII, L.P. Shareholder
Transaction date
Proposed sale
Price
11.50
Quantity 5,883
Value US$67,654
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.67
Quantity 928,110 +13.3%
Value US$1,549,944
MARINUS VERWIJS Officer Officer
Transaction date
Proposed sale
Price
25.00
Quantity 10,600
Value US$265,000
Verwijs Marinus CHIEF TECHNICAL OFFICER Officer
Transaction date
Planned sale
Price
25.00
Quantity 10,600 -100.0%
Value US$265,000
Eldridge George A SEE REMARKS Officer
Transaction date
Planned sale
Price
25.03
Quantity 15,000 -74.9%
Value US$375,450
Gillies Hunter CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
24.50
Quantity 6,000 -51.7%
Value US$147,000
HUNTER C GILLIES Officer Officer
Transaction date
Proposed sale
Price
24.50
Quantity 6,000
Value US$147,000
HUNTER C GILLIES Officer Officer
Transaction date
Proposed sale
Price
21.08
Quantity 4,000
Value US$84,331
Gillies Hunter CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
21.86
Quantity 86 -1.5%
Value US$1,880
Gillies Hunter CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
21.07
Quantity 3,914 -40.8%
Value US$82,452
NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
21.92
Quantity 1,293 -100.0%
Value US$28,345
NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
21.52
Quantity 8,707 -87.1%
Value US$187,410
TIMOTHY NOYES Officer; Director Executive Director
Transaction date
Proposed sale
Price
21.58
Quantity 10,000
Value US$215,755
Verwijs Marinus CHIEF TECHNICAL OFFICER Officer
Transaction date
Planned sale
Price
21.02
Quantity 1,981 -100.0%
Value US$41,631
Verwijs Marinus CHIEF TECHNICAL OFFICER Officer
Transaction date
Planned sale
Price
21.02
Quantity 1,981 -100.0%
Value US$41,631
Verwijs Marinus Officer Officer
Transaction date
Proposed sale
Price
21.02
Quantity 1,981
Value US$41,631
NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
19.91
Quantity 1,357 -100.0%
Value US$27,018
NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
20.87
Quantity 965 -100.0%
Value US$20,135
NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
20.34
Quantity 9,035 -90.3%
Value US$183,793
TIMOTHY NOYES Officer; Director Executive Director
Transaction date
Proposed sale
Price
20.34
Quantity 11,357
Value US$230,945
Gillies Hunter CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
23.33
Quantity 311 -8.7%
Value US$7,255
Gillies Hunter CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
22.30
Quantity 3,689 -50.9%
Value US$82,267
Dake Benjamin T SEE REMARKS Officer
Transaction date
Planned sale
Price
23.97
Quantity 68 -5.0%
Value US$1,630
Dake Benjamin T SEE REMARKS Officer
Transaction date
Planned sale
Price
23.17
Quantity 338 -19.9%
Value US$7,831
Dake Benjamin T SEE REMARKS Officer
Transaction date
Planned sale
Price
22.32
Quantity 6,447 -79.2%
Value US$143,865
Dake Benjamin T Officer Officer
Transaction date
Proposed sale
Price
23.62
Quantity 6,853
Value US$161,868
HUNTER C GILLIES Officer Officer
Transaction date
Proposed sale
Price
22.38
Quantity 4,000
Value US$89,522
NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
24.94
Quantity 5,509 -100.0%
Value US$137,410
NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
24.40
Quantity 4,491 -44.9%
Value US$109,561
TIMOTHY NOYES Officer; Director Executive Director
Transaction date
Proposed sale
Price
24.70
Quantity 10,000
Value US$246,970
Eldridge George A SEE REMARKS Officer
Transaction date
Planned sale
Price
27.56
Quantity 771 -28.2%
Value US$21,252
Eldridge George A SEE REMARKS Officer
Transaction date
Planned sale
Price
26.77
Quantity 6,729 -71.1%
Value US$180,139
3.4
GRAYZEL DAVID S. Non-Executive Director
Transaction date
Sale
Price
28.15
Quantity 11,882 -45.0%
Value US$334,478
Atlas Venture Associates XII, L.P. Director Non-Executive Director
Transaction date
Proposed sale
Price
26.48
Quantity 11,882
Value US$314,635
NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
31.95
Quantity 1,000 -100.0%
Value US$31,950
NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
31.02
Quantity 2,851 -74.0%
Value US$88,446
NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
29.90
Quantity 1,647 -30.0%
Value US$49,238
NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
28.96
Quantity 4,502 -45.0%
Value US$130,399
Verwijs Marinus CHIEF TECHNICAL OFFICER Officer
Transaction date
Planned sale
Price
30.00
Quantity 1,504 -100.0%
Value US$45,118
Verwijs Marinus CHIEF TECHNICAL OFFICER Officer
Transaction date
Planned sale
Price
28.87
Quantity 3,796 -71.6%
Value US$109,579
Dake Benjamin T SEE REMARKS Officer
Transaction date
Planned sale
Price
31.97
Quantity 3,325 -72.0%
Value US$106,317
Eldridge George A SEE REMARKS Officer
Transaction date
Planned sale
Price
31.23
Quantity 12,495 -86.4%
Value US$390,208
Eldridge George A Officer Officer
Transaction date
Proposed sale
Price
29.57
Quantity 37,400
Value US$1,105,918
TIMOTHY NOYES Officer; Director Executive Director
Transaction date
Proposed sale
Price
30.00
Quantity 10,000
Value US$300,033
MARINUS VERWIJS Officer Officer
Transaction date
Proposed sale
Price
29.19
Quantity 5,300
Value US$154,697
Gillies Hunter CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
29.50
Quantity 9,000 -73.5%
Value US$265,500
HUNTER C GILLIES Officer Officer
Transaction date
Proposed sale
Price
29.50
Quantity 9,000
Value US$265,500
Dake Benjamin T SEE REMARKS Officer
Transaction date
Planned sale
Price
27.97
Quantity 11,068 -89.6%
Value US$309,519
Dake Benjamin T SEE REMARKS Officer
Transaction date
Planned sale
Price
28.01
Quantity 3,432 -72.7%
Value US$96,119
Verwijs Marinus CHIEF TECHNICAL OFFICER Officer
Transaction date
Planned sale
Price
26.46
Quantity 2,764 -100.0%
Value US$73,124
Verwijs Marinus CHIEF TECHNICAL OFFICER Officer
Transaction date
Planned sale
Price
25.68
Quantity 2,536 -47.8%
Value US$65,119
MARINUS VERWIJS Officer Officer
Transaction date
Proposed sale
Price
26.08
Quantity 5,300
Value US$138,243
Dake Benjamin T SEE REMARKS Officer
Transaction date
Planned sale
Price
26.48
Quantity 7,581 -85.4%
Value US$200,764
Dake Benjamin T SEE REMARKS Officer
Transaction date
Planned sale
Price
25.74
Quantity 27,476 -75.6%
Value US$707,282
Gillies Hunter CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
26.40
Quantity 613 -15.9%
Value US$16,185
Gillies Hunter CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
25.81
Quantity 6,387 -62.3%
Value US$164,872
Dake Benjamin T Officer Officer
Transaction date
Proposed sale
Price
26.70
Quantity 56,410
Value US$1,506,147
HUNTER C GILLIES Officer Officer
Transaction date
Proposed sale
Price
25.87
Quantity 7,000
Value US$181,056
Eldridge George A SEE REMARKS Officer
Transaction date
Planned sale
Price
25.02
Quantity 2,016 -50.7%
Value US$50,445
Eldridge George A SEE REMARKS Officer
Transaction date
Planned sale
Price
25.05
Quantity 2,051 -51.1%
Value US$51,370
Eldridge George A SEE REMARKS Officer
Transaction date
Planned sale
Price
26.31
Quantity 10 -0.5%
Value US$263
Eldridge George A SEE REMARKS Officer
Transaction date
Planned sale
Price
25.24
Quantity 3,423 -63.5%
Value US$86,404
Eldridge George A SEE REMARKS Officer
Transaction date
Planned sale
Price
25.00
Quantity 114 -5.5%
Value US$2,850
Eldridge George A SEE REMARKS Officer
Transaction date
Planned sale
Price
25.00
Quantity 22,386 -91.9%
Value US$559,688
Gillies Hunter CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
24.50
Quantity 8,975 -73.4%
Value US$219,888
Eldridge George A Officer Officer
Transaction date
Proposed sale
Price
23.87
Quantity 30,000
Value US$716,100
HUNTER C GILLIES Officer Officer
Transaction date
Proposed sale
Price
24.50
Quantity 8,975
Value US$219,888
Gillies Hunter CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
19.50
Quantity 511 -13.6%
Value US$9,964
HUNTER C GILLIES Officer Officer
Transaction date
Proposed sale
Price
19.50
Quantity 511
Value US$9,964
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-25 2025-06-25 PrS Proposed sale
Atlas Venture Fund XII, L.P.

Shareholder
60,746
473.68
US$618,361 		60,746 473.68 US$618,361
2025-06-25 2025-06-25 PrS Proposed sale
Atlas Venture Associates XII, L.P.

Shareholder
57,098
167.80
US$585,597 		57,098 167.80 US$585,597
2025-06-24 2025-06-24 PrS Proposed sale
Atlas Venture Fund XII, L.P.

Shareholder
6,869
315.21
US$2,805,274 		6,869 315.21 US$2,805,274
2025-06-24 2025-06-24 PrS Proposed sale
Atlas Venture Associates XII, L.P.

Shareholder
131
9.87
US$1,293 		131 9.87 US$1,293
2025-05-19 2025-05-16 B Purchase
0.9
Frohlich Tom

Chief Executive Officer

Executive Director
6,000 New position
7.40
US$44,400 		6,000 New position 7.40 US$44,400
2025-05-06 2025-05-06 PrS Proposed sale
Atlas Venture Associates XII, L.P.

Shareholder
48
11.50
US$552 		48 11.50 US$552
2025-05-06 2025-05-06 PrS Proposed sale
Atlas Venture Fund XII, L.P.

Shareholder
5,883
11.50
US$67,654 		5,883 11.50 US$67,654
2024-06-20 2024-06-17 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
928,110 +13.3%
1.67
US$1,549,944 		928,110 +13.3% 1.67 US$1,549,944
2024-06-14 2024-06-14 PrS Proposed sale
MARINUS VERWIJS

Officer

Officer
10,600
25.00
US$265,000 		10,600 25.00 US$265,000
2024-06-14 2024-06-14 PlS Planned sale
Verwijs Marinus

CHIEF TECHNICAL OFFICER

Officer
10,600 -100.0%
25.00
US$265,000 		10,600 -100.0% 25.00 US$265,000
2024-06-14 2024-06-14 PlS Planned sale
Eldridge George A

SEE REMARKS

Officer
15,000 -74.9%
25.03
US$375,450 		15,000 -74.9% 25.03 US$375,450
2024-06-14 2024-06-13 PlS Planned sale
Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
6,000 -51.7%
24.50
US$147,000 		6,000 -51.7% 24.50 US$147,000
2024-06-13 2024-06-13 PrS Proposed sale
HUNTER C GILLIES

Officer

Officer
6,000
24.50
US$147,000 		6,000 24.50 US$147,000
2024-05-17 2024-05-17 PrS Proposed sale
HUNTER C GILLIES

Officer

Officer
4,000
21.08
US$84,331 		4,000 21.08 US$84,331
2024-05-17 2024-05-17 PlS Planned sale
Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
86 -1.5%
21.86
US$1,880 		86 -1.5% 21.86 US$1,880
2024-05-17 2024-05-17 PlS Planned sale
Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
3,914 -40.8%
21.07
US$82,452 		3,914 -40.8% 21.07 US$82,452
2024-05-17 2024-05-16 PlS Planned sale
NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
1,293 -100.0%
21.92
US$28,345 		1,293 -100.0% 21.92 US$28,345
2024-05-17 2024-05-16 PlS Planned sale
NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
8,707 -87.1%
21.52
US$187,410 		8,707 -87.1% 21.52 US$187,410
2024-05-16 2024-05-16 PrS Proposed sale
TIMOTHY NOYES

Officer; Director

Executive Director
10,000
21.58
US$215,755 		10,000 21.58 US$215,755
2024-05-03 2024-05-02 PlS Planned sale
Verwijs Marinus

CHIEF TECHNICAL OFFICER

Officer
1,981 -100.0%
21.02
US$41,631 		1,981 -100.0% 21.02 US$41,631
2024-05-03 2024-05-02 PlS Planned sale
Verwijs Marinus

CHIEF TECHNICAL OFFICER

Officer
1,981 -100.0%
21.02
US$41,631 		1,981 -100.0% 21.02 US$41,631
2024-05-02 2024-05-02 PrS Proposed sale
Verwijs Marinus

Officer

Officer
1,981
21.02
US$41,631 		1,981 21.02 US$41,631
2024-05-03 2024-05-01 PlS Planned sale
NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
1,357 -100.0%
19.91
US$27,018 		1,357 -100.0% 19.91 US$27,018
2024-05-03 2024-05-01 PlS Planned sale
NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
965 -100.0%
20.87
US$20,135 		965 -100.0% 20.87 US$20,135
2024-05-03 2024-05-01 PlS Planned sale
NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
9,035 -90.3%
20.34
US$183,793 		9,035 -90.3% 20.34 US$183,793
2024-05-01 2024-05-01 PrS Proposed sale
TIMOTHY NOYES

Officer; Director

Executive Director
11,357
20.34
US$230,945 		11,357 20.34 US$230,945
2024-04-19 2024-04-17 PlS Planned sale
Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
311 -8.7%
23.33
US$7,255 		311 -8.7% 23.33 US$7,255
2024-04-19 2024-04-17 PlS Planned sale
Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
3,689 -50.9%
22.30
US$82,267 		3,689 -50.9% 22.30 US$82,267
2024-04-19 2024-04-17 PlS Planned sale
Dake Benjamin T

SEE REMARKS

Officer
68 -5.0%
23.97
US$1,630 		68 -5.0% 23.97 US$1,630
2024-04-19 2024-04-17 PlS Planned sale
Dake Benjamin T

SEE REMARKS

Officer
338 -19.9%
23.17
US$7,831 		338 -19.9% 23.17 US$7,831
2024-04-19 2024-04-17 PlS Planned sale
Dake Benjamin T

SEE REMARKS

Officer
6,447 -79.2%
22.32
US$143,865 		6,447 -79.2% 22.32 US$143,865
2024-04-17 2024-04-17 PrS Proposed sale
Dake Benjamin T

Officer

Officer
6,853
23.62
US$161,868 		6,853 23.62 US$161,868
2024-04-17 2024-04-17 PrS Proposed sale
HUNTER C GILLIES

Officer

Officer
4,000
22.38
US$89,522 		4,000 22.38 US$89,522
2024-04-18 2024-04-16 PlS Planned sale
NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
5,509 -100.0%
24.94
US$137,410 		5,509 -100.0% 24.94 US$137,410
2024-04-18 2024-04-16 PlS Planned sale
NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
4,491 -44.9%
24.40
US$109,561 		4,491 -44.9% 24.40 US$109,561
2024-04-16 2024-04-16 PrS Proposed sale
TIMOTHY NOYES

Officer; Director

Executive Director
10,000
24.70
US$246,970 		10,000 24.70 US$246,970
2024-04-12 2024-04-10 PlS Planned sale
Eldridge George A

SEE REMARKS

Officer
771 -28.2%
27.56
US$21,252 		771 -28.2% 27.56 US$21,252
2024-04-12 2024-04-10 PlS Planned sale
Eldridge George A

SEE REMARKS

Officer
6,729 -71.1%
26.77
US$180,139 		6,729 -71.1% 26.77 US$180,139
2024-04-11 2024-04-09 S Sale
3.4
GRAYZEL DAVID S.
Non-Executive Director
11,882 -45.0%
28.15
US$334,478 		11,882 -45.0% 28.15 US$334,478
2024-04-09 2024-04-09 PrS Proposed sale
Atlas Venture Associates XII, L.P.

Director

Non-Executive Director
11,882
26.48
US$314,635 		11,882 26.48 US$314,635
2024-04-03 2024-04-01 PlS Planned sale
NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
1,000 -100.0%
31.95
US$31,950 		1,000 -100.0% 31.95 US$31,950
2024-04-03 2024-04-01 PlS Planned sale
NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
2,851 -74.0%
31.02
US$88,446 		2,851 -74.0% 31.02 US$88,446
2024-04-03 2024-04-01 PlS Planned sale
NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
1,647 -30.0%
29.90
US$49,238 		1,647 -30.0% 29.90 US$49,238
2024-04-03 2024-04-01 PlS Planned sale
NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
4,502 -45.0%
28.96
US$130,399 		4,502 -45.0% 28.96 US$130,399
2024-04-03 2024-04-01 PlS Planned sale
Verwijs Marinus

CHIEF TECHNICAL OFFICER

Officer
1,504 -100.0%
30.00
US$45,118 		1,504 -100.0% 30.00 US$45,118
2024-04-03 2024-04-01 PlS Planned sale
Verwijs Marinus

CHIEF TECHNICAL OFFICER

Officer
3,796 -71.6%
28.87
US$109,579 		3,796 -71.6% 28.87 US$109,579
2024-04-03 2024-04-01 PlS Planned sale
Dake Benjamin T

SEE REMARKS

Officer
3,325 -72.0%
31.97
US$106,317 		3,325 -72.0% 31.97 US$106,317
2024-04-03 2024-04-01 PlS Planned sale
Eldridge George A

SEE REMARKS

Officer
12,495 -86.4%
31.23
US$390,208 		12,495 -86.4% 31.23 US$390,208
2024-04-01 2024-04-01 PrS Proposed sale
Eldridge George A

Officer

Officer
37,400
29.57
US$1,105,918 		37,400 29.57 US$1,105,918
2024-04-01 2024-04-01 PrS Proposed sale
TIMOTHY NOYES

Officer; Director

Executive Director
10,000
30.00
US$300,033 		10,000 30.00 US$300,033
2024-04-01 2024-04-01 PrS Proposed sale
MARINUS VERWIJS

Officer

Officer
5,300
29.19
US$154,697 		5,300 29.19 US$154,697
2024-04-01 2024-03-28 PlS Planned sale
Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
9,000 -73.5%
29.50
US$265,500 		9,000 -73.5% 29.50 US$265,500
2024-03-28 2024-03-28 PrS Proposed sale
HUNTER C GILLIES

Officer

Officer
9,000
29.50
US$265,500 		9,000 29.50 US$265,500
2024-03-28 2024-03-27 PlS Planned sale
Dake Benjamin T

SEE REMARKS

Officer
11,068 -89.6%
27.97
US$309,519 		11,068 -89.6% 27.97 US$309,519
2024-03-27 2024-03-25 PlS Planned sale
Dake Benjamin T

SEE REMARKS

Officer
3,432 -72.7%
28.01
US$96,119 		3,432 -72.7% 28.01 US$96,119
2024-03-20 2024-03-19 PlS Planned sale
Verwijs Marinus

CHIEF TECHNICAL OFFICER

Officer
2,764 -100.0%
26.46
US$73,124 		2,764 -100.0% 26.46 US$73,124
2024-03-20 2024-03-19 PlS Planned sale
Verwijs Marinus

CHIEF TECHNICAL OFFICER

Officer
2,536 -47.8%
25.68
US$65,119 		2,536 -47.8% 25.68 US$65,119
2024-03-19 2024-03-19 PrS Proposed sale
MARINUS VERWIJS

Officer

Officer
5,300
26.08
US$138,243 		5,300 26.08 US$138,243
2024-03-20 2024-03-18 PlS Planned sale
Dake Benjamin T

SEE REMARKS

Officer
7,581 -85.4%
26.48
US$200,764 		7,581 -85.4% 26.48 US$200,764
2024-03-20 2024-03-18 PlS Planned sale
Dake Benjamin T

SEE REMARKS

Officer
27,476 -75.6%
25.74
US$707,282 		27,476 -75.6% 25.74 US$707,282
2024-03-20 2024-03-18 PlS Planned sale
Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
613 -15.9%
26.40
US$16,185 		613 -15.9% 26.40 US$16,185
2024-03-20 2024-03-18 PlS Planned sale
Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
6,387 -62.3%
25.81
US$164,872 		6,387 -62.3% 25.81 US$164,872
2024-03-18 2024-03-18 PrS Proposed sale
Dake Benjamin T

Officer

Officer
56,410
26.70
US$1,506,147 		56,410 26.70 US$1,506,147
2024-03-18 2024-03-18 PrS Proposed sale
HUNTER C GILLIES

Officer

Officer
7,000
25.87
US$181,056 		7,000 25.87 US$181,056
2024-03-14 2024-03-13 PlS Planned sale
Eldridge George A

SEE REMARKS

Officer
2,016 -50.7%
25.02
US$50,445 		2,016 -50.7% 25.02 US$50,445
2024-03-14 2024-03-12 PlS Planned sale
Eldridge George A

SEE REMARKS

Officer
2,051 -51.1%
25.05
US$51,370 		2,051 -51.1% 25.05 US$51,370
2024-03-11 2024-03-11 PlS Planned sale
Eldridge George A

SEE REMARKS

Officer
10 -0.5%
26.31
US$263 		10 -0.5% 26.31 US$263
2024-03-11 2024-03-11 PlS Planned sale
Eldridge George A

SEE REMARKS

Officer
3,423 -63.5%
25.24
US$86,404 		3,423 -63.5% 25.24 US$86,404
2024-03-11 2024-03-08 PlS Planned sale
Eldridge George A

SEE REMARKS

Officer
114 -5.5%
25.00
US$2,850 		114 -5.5% 25.00 US$2,850
2024-03-11 2024-03-07 PlS Planned sale
Eldridge George A

SEE REMARKS

Officer
22,386 -91.9%
25.00
US$559,688 		22,386 -91.9% 25.00 US$559,688
2024-03-11 2024-03-07 PlS Planned sale
Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
8,975 -73.4%
24.50
US$219,888 		8,975 -73.4% 24.50 US$219,888
2024-03-07 2024-03-07 PrS Proposed sale
Eldridge George A

Officer

Officer
30,000
23.87
US$716,100 		30,000 23.87 US$716,100
2024-03-07 2024-03-07 PrS Proposed sale
HUNTER C GILLIES

Officer

Officer
8,975
24.50
US$219,888 		8,975 24.50 US$219,888
2024-02-27 2024-02-23 PlS Planned sale
Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
511 -13.6%
19.50
US$9,964 		511 -13.6% 19.50 US$9,964
2024-02-23 2024-02-23 PrS Proposed sale
HUNTER C GILLIES

Officer

Officer
511
19.50
US$9,964 		511 19.50 US$9,964

See older Jade Biosciences, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Jade Biosciences, Inc. history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Jade Biosciences, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America